Anhui Fengyuan Pharmaceutical Co., Ltd. researches and develops, produces, and sells medicines in China. The company offers biopharmaceuticals, chemical pharmaceuticals, traditional Chinese medicine preparations, processed Chinese medicinal herbs, and raw materials. It also provides antipyretics and analgesics, gynecological and pediatric drugs, nervous system drugs, cardiovascular system drugs, urinary system drugs, nutritional drugs, and antibiotics. Anhui Fengyuan Pharmaceutical Co., Ltd. was founded in 1997 and is based in Hefei, China.
Research context
Anhui Fengyuan Pharmaceutical Co., Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Anhui Fengyuan Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 16.0% above its 200 day moving average.
From a valuation standpoint, the stock is 92.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.7.
Anhui Fengyuan Pharmaceutical Co., Ltd's total revenue rose by 3.8% to $849M since the same quarter in the previous year.
Its net income has dropped by 30.6% to $13M since the same quarter in the previous year.
Finally, its free cash flow fell by 791.8% to $-21M since the same quarter in the previous year.
Based on the above factors, Anhui Fengyuan Pharmaceutical Co., Ltd gets an overall score of 3/5.